GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
8.17567 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CYP1B1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
8.12407 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.72376 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CYP1B1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
7.67357 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CYP1B1, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
7.43063 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1B1, FABP4, KDR, MMP9, PTGS2, SRC, TERT |
7.43063 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FUT7, GLO1, IDO1, PIM1, PTGS2, XDH |
7.42438 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
7.26514 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
7.10256 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, FABP3, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
6.85907 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
6.81998 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
6.81998 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT |
6.47168 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CDC25B, CYP1B1, FABP3, FLT3, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
6.13729 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
6.10387 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
6.09209 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CA9, CYP1A1, CYP1B1, DHFR, FABP3, GSK3B, IDO1, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC |
6.01272 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
5.9515 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MMP2, PTGS2, RORC, SRC |
5.65875 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MMP2, MMP9, PTGS2, RORC, SRC, TERT |
5.65875 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
5.61295 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
5.41612 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, APEX1, APP, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, MMP9, PTGS2, RORC, SRC, TERT |
5.18402 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
5.18402 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, MET, MMP2, MMP9, PIM1, PTGS2, RORC, SRC, TERT, TOP2A |
5.18402 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
4.88062 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, KDR, MET, PTGS2, SRC, TERT, XDH |
4.83652 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.7074 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
4.69647 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, APEX1, APP, AXL, CYP1A1, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, MMP2, PTGS2, RORC, SRC |
4.68837 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
4.53238 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
4.5258 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DHFR, FABP4, GSK3B, IDO1, IGF1R, MET, MMP12, MMP2, PTGS2, PTPN1, SRC, TERT, XDH |
4.51402 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, GSK3B, IGF1R, MMP2, MMP9, PTGS2, RORC, SRC |
4.41867 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, FABP4, FLT3, GSK3B, IDO1, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.41867 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, FLT3, GSK3B, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
4.33284 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MMP12, MMP2, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
4.18373 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
4.14535 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, MET, PTGS2 |
3.9396 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
3.91777 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, CA2, CA7, CYP19A1, CYP1B1, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT |
3.88862 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, SRC, TERT |
3.81109 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1B1, DHFR, GSK3B, IDO1, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, TOP2A |
3.78198 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, IDO1 |
3.72717 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APEX1, APP, CA2, CA9, CYP1A1, CYP1B1, DHFR, FLT3, PTGS2, RORC, SRC |
3.72717 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1B1, DHFR, GSK3B, IDO1, PTGS2, XDH |
3.72443 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DHFR, FABP3, KDR, PTGS2, SRC |
3.69072 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, XDH |
3.68431 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.56896 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
3.56792 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.55826 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, MMP9, PTGS2, SRC |
3.51545 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
3.48545 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, IGF1R, PTGS2, SRC |
3.47824 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APEX1, APP, CYP1A1, CYP1B1, FLT3, PTGS2, RORC, SRC |
3.47487 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, FABP3, FABP4, FLT3, MET, SRC, TERT |
3.47487 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, APEX1, APP, AURKB, AXL, CDC25B, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, PTGS2, PTPN1, SRC, XDH |
3.47487 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, AXL, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
3.45884 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CYP1B1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PTGS2, PTPN1, SRC |
3.44149 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, FLT3, KDR, MET, PTGS2, PTPN1, SRC, XDH |
3.43777 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
3.42542 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APEX1, APP, CA2, CA9, FABP3, FLT3, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.41669 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.37461 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, APP, AXL, CDC25B, CYP1A1, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, MET, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A |
3.35007 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.3452 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.15476 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, SRC |
3.15235 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PTGS2, SRC |
3.08041 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
3.06166 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.01836 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CYP1A1, FABP3, FLT3, IDO1, PTGS2, RORC, SRC |
3.0132 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3 |
3.00631 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.99302 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, APEX1, AXL, CA2, CA9, CYP1B1, DHFR, GSK3B, MMP9, PTGS2, PTPN1, SRC, TERT, TOP2A |
2.98844 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.96835 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.95123 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CYP19A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.95123 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.95123 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1B1 |
2.91096 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, AXL, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.90938 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.90072 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.89591 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.89007 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.88314 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CYP1B1, FLT3, IGF1R, KDR, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.86311 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, FABP4, MMP9, PTGS2, TERT |
2.82267 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, SRC |
2.81695 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, KDR, MMP2, PTGS2, SRC |
2.80572 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.80572 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, GSK3B, MMP12, PTGS2, SRC, TERT |
2.80233 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.80025 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.80025 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.73927 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AURKB, AXL, CDC25B, CYP1A1, DHFR, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, SRC, TOP2A, XDH |
2.73157 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.73052 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.7045 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CDC25B, DHFR, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.69219 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.68428 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, SRC, TERT |
2.67676 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, IGF1R, KDR, MET, MMP9, PTGS2, SRC, TERT |
2.64491 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, GSK3B, IGF1R, MET, PTGS2, PTPN1, TERT, XDH |
2.63348 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, CDC25B, FABP3, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.60286 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.60282 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.60282 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.58081 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, PTGS2, RORC, SRC |
2.55239 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.55239 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.53094 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.50983 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, SRC, TERT |
2.50539 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.50511 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1 |
2.50511 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, FLT3, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.50511 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.47742 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.46716 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.44535 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, APP, AXL, CYP19A1, CYP1B1, FABP4, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, RORC, SRC |
2.44147 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.44111 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, FABP3, IDO1, PTGS2, TERT, XDH |
2.42676 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CYP1B1, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
2.42676 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, DHFR, FABP4, FLT3, GSK3B, IGF1R, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.42676 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PTGS2, SRC, TERT |
2.41805 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, FLT3, FUT7, GLO1, MMP9, RORC |
2.40449 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.40449 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, FABP3, FLT3, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.39946 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, FABP3, FLT3, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.39946 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3 |
2.39946 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, CYP19A1, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, GSK3B, IDO1, XDH |
2.39537 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.37392 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PTGS2, SRC, TERT |
2.37306 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.37117 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.37117 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.37117 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1A1, CYP1B1, KDR, SRC |
2.3658 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1B1, FABP3, FABP4 |
2.36518 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, DHFR, FABP4, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, XDH |
2.35175 |
[BP] GO:0051099 |
positive regulation of binding
|
APP, GSK3B, MET, MMP9, TERT |
2.34925 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CDC25B, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.34486 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.34442 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, TERT |
2.34272 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, APP, AXL, CDC25B, CYP19A1, CYP1A1, IDO1, MMP2, MMP9, PTGS2, SRC, TOP2A |
2.3289 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTGS2 |
2.31051 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, DHFR |
2.30828 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CYP19A1, GSK3B, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT |
2.28962 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.28256 |
[BP] GO:0032092 |
positive regulation of protein binding
|
APP, GSK3B, MMP9, TERT |
2.28256 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.28045 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, FLT3, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.2802 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, FABP4, FLT3, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.28005 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.27767 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.27497 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PTGS2, SRC, TERT |
2.23211 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CYP1A1, CYP1B1, FABP3, FABP4, FUT7, MET, PTGS2 |
2.22577 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.20576 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.20576 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, PTGS2 |
2.18405 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, MET, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, XDH |
2.16955 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, PTGS2 |
2.16955 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, PTGS2 |
2.16955 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, FABP4, IDO1, MMP12, MMP2, PTGS2, PTPN1, SRC |
2.16601 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CYP1B1, GSK3B, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.1632 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CDC25B, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
2.16023 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1 |
2.16023 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, CDC25B, FLT3, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.16023 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
MMP9, PTGS2, PTPN1, SRC |
2.14455 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CYP1B1, GSK3B, IDO1, MMP9, PTGS2, SRC, TOP2A, XDH |
2.14455 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CYP1B1, FLT3, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.11994 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, MMP2, PTGS2, SRC, TERT |
2.11806 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1B1, PTGS2 |
2.1165 |
[BP] GO:1900087 |
None
|
APEX1, CYP1A1, TERT |
2.09086 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, GSK3B, MMP12, PTGS2, PTPN1, SRC |
2.09086 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, PTPN1, SRC |
2.09012 |
[BP] GO:0034405 |
response to fluid shear stress
|
CA2, PTGS2, SRC |
2.06439 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CYP19A1, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.03363 |
[BP] GO:0007566 |
embryo implantation
|
MMP2, MMP9, PTGS2 |
2.03358 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.0289 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, KDR, PTGS2, SRC |
2.02462 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1B1, PTGS2 |
2.02419 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, CDC25B, DHFR, FLT3, GSK3B, MET, MMP9, PTPN1, SRC, TERT, XDH |
2.01724 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.01013 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1B1, FABP3, GLO1, IDO1, PTGS2 |
2.01013 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CYP1B1, GSK3B, IDO1, KDR, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT, XDH |
2.00809 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.00762 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00607 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, CDC25B, FABP4, FLT3, IGF1R, KDR, MMP9, PTGS2, PTPN1, SRC, XDH |
2.00607 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CYP19A1, FLT3, KDR, PTGS2, PTPN1, XDH |
2.28962 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.09086 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP |
1.8987 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, CA1, CA2, CA4, CA7, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, FUT7, GLO1, GSK3B, IDO1, KDR, MMP2, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
1.77697 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, APP, AXL, CA12, CA14, CA2, CA4, CA9, FLT3, GLO1, GSK3B, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TERT |
1.52895 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.7371 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CYP19A1, CYP1A1, CYP1B1, DHFR, FLT3, FUT7, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
10.7371 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, RORC, XDH |
9.64388 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, DHFR, FABP3, FABP4, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH |
9.324 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.76095 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.25091 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
6.49002 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, TERT, TOP2A, XDH |
5.65875 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1B1, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PTGS2, PTPN1, RORC, TERT, TOP2A, XDH |
5.18402 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PTPN1, RORC |
4.94368 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.91468 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1B1, IDO1, PTGS2, SRC |
3.7667 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1B1, DHFR, IDO1, PTGS2, XDH |
3.72443 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1B1, IDO1, PTGS2, SRC |
3.62626 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.50368 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
3.07144 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1A1, CYP1B1, DHFR, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TOP2A |
3.06513 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PTPN1, SRC |
2.74136 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PTPN1, SRC |
2.72892 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1B1, DHFR, IDO1, PTGS2, SRC, XDH |
2.67367 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.61582 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1B1 |
2.50539 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1B1 |
2.39946 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.39946 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1B1, XDH |
2.37117 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.37117 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.23904 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC |
2.16955 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MET, PIM1, SRC, TERT |
2.09364 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.09086 |